Deka BioSciences, Inc. announced that it will receive $41,386,483 in funding on February 6, 2023. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.93 PLN | +0.61% | +2.49% | +23.25% |
Mar. 28 | Transcript : Echo Investment S.A., 2023 Earnings Call, Mar 28, 2024 | |
Mar. 27 | Echo Investment S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.25% | 517M | |
+0.81% | 26.08B | |
-12.14% | 14.18B | |
+14.38% | 11.33B | |
-23.48% | 7.84B | |
-6.94% | 6.92B | |
+7.06% | 6.9B | |
+4.15% | 6.82B | |
-1.97% | 3.75B | |
+9.35% | 3.51B |
- Stock Market
- Equities
- ECH Stock
- News Echo Investment S.A.
- Deka BioSciences, Inc. announced that it expects to receive funding